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Abstract
To further investigate the immunosuppressive activity of cholesterylphosphoserine (CPHS), we examined a variety of
human T cell responses including proliferation, adhesion and cytoskeletal organization. The CPHS-induced inhibition of T
cell response is greater in the integrin-dependent mixed lymphocyte reaction than in the integrin-independent proliferation
elicited by anti-TCR-CD3 or anti-CD28 antibodies in the presence of tetradecanoylphorbol acetate. Consistently, CPHS
inhibits the homotypic T cell adhesion involving the integrin KLL2 (LFA-1) and the cell adhesion to fibronectin and rVCAM-
1 involving the integrins of the L1 family. Since CPHS does not change integrin expression but inhibits post-receptor events
such as cell spreading and pseudopodal projections, it seems likely that the site of CPHS influence is distal to the adhesion
receptors. In agreement, the steroid prevents the reorganization of actin cytoskeleton occurring when T cells are allowed to
spread on immobilized anti-CD3 in the absence of integrin activation. We suggest that CPHS acts on the metabolic pathway
in which signals from integrin and growth factor receptors converge to induce the reorganization of the actin cytoskeleton.
Selectivity in the action of CPHS is indicated by its ineffectiveness in the integrin-mediated adhesion of the monocytic cell line
U-937 to fibronectin. ß 1999 Elsevier Science B.V. All rights reserved.
Keywords: Cholesterylphosphoserine; T cell ; Cell adhesion; Integrin; Actin polymerization; Immunosuppression
1. Introduction
Currently used immunosuppressants act on a vari-
ety of cell functions including DNA synthesis, the
assembly of transcription factors for the interleu-
kin-2 gene and the enzymes regulating the cell cycle.
Notable examples are mycophenolic acid, a selective
inhibitor of type II isoform of inosine monophos-
phate dehydrogenase [1], the immunophilin-related
drugs cyclosporin A and tacrolimus acting on the
Ca2-dependent assembly of the nuclear factor of
activated T cells [2], and sirolimus which inhibits
the phosphorylation of p70 S6 kinase, required for
the progression of T cells through the G1 phase of
the cell cycle [3]. Progress in understanding the T cell
immune response suggests that plasma membrane
may be an alternative target of immunosuppressants.
Cell-cell recognition as well as the transmission of
signals inside the T cells depend on the aggregation
of surface receptors migrating within the plane of
plasma membrane. In addition, key signaling pro-
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teins such as protein kinase C and Rho GTPases
need to translocate to the plasma membrane in order
to perform their function. On this basis it can be
predicted that drugs changing the lipid organization
of plasma membrane may a¡ect these events. To this
end steroid compounds seem suitable as their inser-
tion into the plasma membrane is followed by an
increase in lipid packing, in£uencing protein mobility
and conformational changes [4]. In addition, they
may interact with selected proteins. A preferential
distribution of signaling proteins and steroids in the
sphingolipid-cholesterol microdomains of plasma
membrane [5] may favor this interaction. An example
of steroid drugs acting in the plasma membrane is
progesterone that inhibits the MDR glycoprotein-P
[6] and the oxytocin receptor [7]. Following this line,
we have developed a new synthetic cholesteryl ester,
cholesterylphosphoserine (CPHS), that shows immu-
nosuppressive activity [8,9]. More recently [10], we
have shown that CPHS inserts its steroid ring into
the T cell plasma membrane exposing the negatively
charged phosphoserine group outside the cell. A con-
sequence of CPHS insertion into the cell is the inhi-
bition of cholesterol transport from the plasma mem-
brane to the endoplasmic reticulum. These results
suggest that CPHS may become a reagent to study
T cell functions requiring the integrity of plasma
membrane organization. A study has therefore been
undertaken to investigate the e¡ect of CPHS on the
signaling activity of mitogenic and adhesive recep-
tors. Our data show that a major consequence of
CPHS insertion into the T cell membrane is the in-
hibition of the signaling pathway connecting these
surface receptors to the organization of the actin
cytoskeleton.
2. Materials and methods
2.1. Reagents
Monoclonal antibodies (mAbs) used were: anti-
CD11a (anti-LFA-1), clone 38 and anti-CD3, clone
UCHT1 from Ancell, anti-CD28, clone 15E8 from
Cymbus Biotechnology, anti-CD49d (anti-VLA-4)
clone SG/37 and anti-CD49e (anti-VLA-5) clone
KH/33 from Seikagaku. The anti-CD 29 (anti-L1
integrins) was the BV7 mAb from Bioline [11].
Recombinant vascular cell adhesion molecule-1
(rVCAM-1) was a kind gift from Dr. R. Lobb (Bio-
gen, Cambridge, MA, USA).
A saline bu¡ered medium (TBS) used in some ex-
periment had the following composition: 120 mM
NaCl, 5 mM KCl, 0.4 mM CaCl2, 2.5 mM MgCl2,
25 mM Tris-HCl (pH 7.4). Cyclosporin A (Sandoz)
was dissolved at 1 mg/ml in 50% ethanol. Cholester-
yl-3L-phospho-L-serine (CPHS, Fig. 1), a generous
gift from Dr. G. Kirschner (Fidia Research Labora-
tories, Padua, Italy) was dispersed at 1 mg/ml in 50%
ethanol containing 5 mM Tris-HCl, pH 7.8, and
brie£y warmed at 50‡C to obtain a clear solution
which could be stored at 4‡C for a week. The ¢nal
CPHS concentration was veri¢ed by phosphorus de-
termination. Cholesterol, cholesteryl acetate, choles-
teryl-3L-phosphocholine (Fluka) and progesterone
(Sigma) were dissolved and added in ethanol. The
e¡ect of the ethanol concentration added with all
these compounds was routinely controlled.
2.2. Cell cultures
The human leukemic T cell line Jurkat, the human
T lymphoma cell line SKW-3 and the human mono-
blastic-monocytic cell line U-937 were maintained in
RPMI 1640 medium supplemented with 10% (v/v)
fetal calf serum, 2 mM L-glutamine, and antibiotics.
Peripheral blood mononuclear cells from healthy do-
nors were isolated from heparinized venous blood by
density gradient centrifugation using Ficoll-Paque.
To deplete monocytes, T cells were separated by ro-
setting with neuraminidase-treated sheep erythro-
cytes, and further treated with 5 mM leucine methyl
ester. The purity of the preparation was evaluated by
the proliferation index obtained when one or two
stimulating signals were applied to puri¢ed T cells.
In our preparation the proliferation index increased
approx. 10 times when 10 nM of tetradecanoylphor-
bol acetate (TPA) was added with 0.1 Wg of immo-
bilized anti-CD3 mAb. Non-speci¢c cytotoxicity in-
duced by CPHS in prolonged incubations was
assessed by the trypan blue exclusion test and by
the reduction of MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide) added to the cul-
tures. To further evaluate a possible cell damage in
the critical time of T cell activation (the ¢rst 24 h of
incubation), 1 WCi of [3H]oleate or [3H]leucine was
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added at the beginning of the cell culture. After 24 h,
the energy-dependent incorporation of oleate into
phospholipids or of leucine into cell proteins was
determined.
2.3. T cell proliferation
Puri¢ed T cells (105) were incubated in microtiter
plates at 37‡C in 0.2 ml of RPMI medium containing
5% fetal calf serum (v/v), 1 mg/ml of bovine serum
albumin (BSA), 2 mM L-glutamine, 50 Wg/ml of
transferrin, 100 U/ml of penicillin and 100 Wg/ml of
streptomycin. 1 WCi of [3H]thymidine (TdR) was
added in the last 18 h of culture. Cell activation
was induced by 0.1 Wg/well of immobilized anti-
CD3 mAb (overnight incubation of the antibody
added to wells at 4‡C, followed by washing) or
0.2 Wg/well of anti-CD28 mAb, each combined with
10 nM of TPA. Under these conditions the incuba-
tion time was 72 h at 37‡C. Alternatively, T cell
response was elicited by mixing 105 irradiated (3000
rad) allogeneic mononuclear cells with the same
number of puri¢ed T cells in 0.2 ml of RPMI me-
dium, supplemented as described above (mixed lym-
phocyte reaction). The incubation time was 6 days at
37‡C.
2.4. Homotypic T cell adhesion
Puri¢ed T cells or SKW-3 cells (2U105 in 0.2 ml of
TBS containing 2.5% fetal calf serum and 50 nM of
TPA) were incubated with and without CPHS for 20
h at 37‡C. Cell aggregation was then examined by an
inverted microscope and photographed. The involve-
ment of the integrin KLL2 (LFA-1) in this process
was tested by an antibody directed against the K
subunit of the integrin (anti-CD11a). Quantitative
evaluation of the CPHS e¡ect was obtained by a
computerized video imaging system coupled to an
inverted microscope. Images of cell aggregates were
acquired by a CCD camera, digitalized by an image
processor and stored in a personal computer for
analysis. To improve the quality of the digitalized
pictures, each image was obtained by averaging 32
video frames. The area of cell aggregates was calcu-
lated in 25 ¢elds by a custom-built software, and
expressed as the number of pixels/¢eld.
2.5. Adhesion and spreading on immobilized peptides
Wells of microtiter plates were coated with 2 Wg of
¢bronectin or 0.2 Wg rVCAM-1 according to estab-
lished procedures, 1% BSA was used to block non-
speci¢c sites of adhesion. Jurkat or U-937 cells (106/
ml) were preincubated for 30 min at 37‡C in the
absence and in the presence of CPHS in RPMI con-
taining 10% (v/v) of a low-lipid serum replacement
(Sigma CPSR-1) which had the advantage of avoid-
ing CPHS dispersion into serum lipoproteins. Under
this condition CPHS readily incorporated into the
cells [10]. When indicated, TPA (20 nM) was also
added during this preincubation to enhance the in-
tegrin-mediated cell adhesion [12]. After centrifuga-
tion and washing, 2U105 cells resuspended in RPMI
containing 1 mg/ml of BSA were added to peptide-
coated wells, and incubated for 60 min at 37‡C. In
the comparison between Jurkat and U-937 cells the
concentration of BSA was increased to 10 mg/ml
[13]. The wells were washed three times, and the at-
tached cells were ¢xed with 2.5% glutardialdehyde in
TBS. Adhesion was measured by staining the cells
with 0.5% toluidine blue in 2.5% glutardialdehyde,
and by reading at 630 nm, after dye extraction
with 2% sodium dodecyl sulfate. 100% adherence,
calculated by ¢xing the cells before washing, gave
an absorbance value of 0.7^0.8. The spread morphol-
ogy in ¢xed cells was evaluated using phase contrast
microscopy. Alternatively, the adhesion was allowed
to occur in a coverslip coated with ¢bronectin. The
samples were post¢xed with 1% osmic acid, dehy-
drated and critical point dried. After shadowing
with Au-Pd, the samples were examined with scan-
ning electron microscope.
2.6. Actin polymerization
The assay for the actin polymerization in adherent
cells was performed as described [14]. Brie£y, 2U105
control and CPHS-treated Jurkat cells in TBS con-
taining 1 mg/ml of BSA were incubated for 10 min at
37‡C on a glass coverslips coated (overnight incuba-
tion at 4‡C followed by washing) with 1 Wg of anti-
CD3 mAb. The coverslips were washed, and the
bound cells ¢xed for 30 min at 4‡C with 2% para-
formaldehyde in PBS. After 20 min permeabilization
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with 0.1% Triton X-100 in PBS at 20‡C, the cover-
slips were incubated for 45 min at 20‡C in PBS con-
taining 1% fetal calf serum. Cells were then exposed
to 1 Wg/ml of FITC-conjugated phalloidin (Sigma)
for 20 min in the dark at room temperature. Cover-
slips were washed and observed in a Zeiss £uores-
cence microscope.
2.7. Protein kinase C activity
Jurkat cells (2.5U107) were incubated for 15 min
at 37‡C with 10 or 20 WM of CPHS in 10 ml of TBS
supplemented with 1 mg/ml of BSA and 23 WM of
leupeptin to avoid protein kinase C (PKC) degrada-
tion [15]. 20 nM of TPA was then added to initiate
the translocation of PKC into the cell membranes,
and the incubation followed for an additional 10
min. Cytosolic and membrane-associated PKC were
extracted, partially puri¢ed on DEAE-cellulose, and
assayed as described [16] with the following modi¢-
cations: 40 WM leupeptin and 15 WM aprotinin were
included in the lysis bu¡er; particulate PKC was
extracted with 0.25% Triton X-100; the assay was
conducted for 10 min at 37‡C after the addition of
50 WM ATP containing 3 WCi of [Q-33P]ATP (Amer-
sham).
2.8. Lipid analysis
U-937 cells (107) were extracted with 20 vols. of
chloroform-methanol 2:1 (v/v). The lipid extract,
washed twice with 0.2 vol. of 0.1 M HCl, was taken
to dryness and tested for total cholesterol content by
a Sigma diagnostic kit based on the sequential action
of cholesterol esterase and cholesterol oxidase. Phos-
pholipids were resolved by TLC and quanti¢ed by
phosphorus determination [10].
2.9. Flow cytometry
The expression of CD11a (the K subunit of LFA-
1) in SKW-3 cells or CD29 (the L1 subunit of integ-
rins) in Jurkat cells was measured by indirect immu-
no£uorescence using a £uorescence-activated cell
sorter (Epics Elite Coulter). Cells (106/ml) were pre-
treated with 10 WM of CPHS in the conditions de-
scribed for the determination of homotypic cell ad-
hesion (3 h of preincubation) or for the adhesion to
¢bronectin (30 min of preincubation). After centrifu-
gation and washing with RPMI medium containing
1% (v/v) of fetal calf serum, cells were resuspended in
the same medium at 7U106 cells/ml and incubated
with the primary antibody (anti-CD11a or BV7) for
45 min at 0‡C. After two washes, £uorescein-labeled
goat anti-mouse IgG antibody was added and the
cells incubated an additional 45 min. Controls were
obtained omitting the primary antibody.
3. Results
3.1. T cell proliferation
To study the action of CPHS, we used two stim-
ulating conditions for puri¢ed T cells. The ¢rst was a
two-signal model of T cell activation, independent of
the integrin-mediated cell-to-cell contact. The second
was the integrin-dependent mixed lymphocyte reac-
tion. To enhance CPHS incorporation, T cells were
treated with the steroid and with the activating stim-
uli in the presence of 1 mg/ml of BSA. Fetal calf
serum was added 10 min later. Since these experi-
ments required a long period of incubation, several
tests were performed to exclude non-speci¢c, CPHS-
induced cytotoxicity. Trypan blue exclusion and
Fig. 1. Structure of cholesteryl-3L-phospho-L-serine.
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MTT reduction tests performed at 24, 48 and 72 h of
incubation showed that CPHS up to 10 WM did not
cause loss of cell viability under the present condi-
tions. Particularly, unchanged energy-dependent in-
corporation of [3H]oleate into phospholipids or
[3H]leucine into proteins indicated that CPHS did
not produce loss of high-energy compounds during
the ¢rst 24 h of incubation, the time in which the
signals from the surface receptors were transmitted
to the T cell nucleus. We also considered the possi-
bility that the CPHS-induced inhibitory e¡ect on T
cell proliferation was the consequence of inhibition
of transferrin metabolism, previously documented
with cholesterol [17]. To avoid this e¡ect transferrin
was included in the incubation medium.
As shown in Table 1, T cells proliferated when
challenged with two signals activating a calcium-de-
pendent pathway (immobilized anti-CD3 mAb in the
presence of TPA) and a calcium-independent path-
way (anti-CD28 in the presence of TPA). Under
these conditions CPHS caused a signi¢cant but mod-
est inhibition of T cell proliferation. As expected, an
antibody (anti-CD11a), directed against the K sub-
unit of the integrin KLL2 (LFA-1) did not inhibit pro-
liferation, con¢rming that the integrin-mediated cell-
to-cell contact was not required. Although at a lower
extent, puri¢ed T cells also proliferated when chal-
lenged with irradiated allogeneic mononuclear cells.
This immune response was partially inhibited by the
anti-CD11a mAb and completely by cyclosporin A.
This result was consistent with the participation of
LFA-1-mediated cell-to-cell adhesion in the mixed
lymphocyte reaction [18]. In this model, the inhibi-
tion by CPHS was more evident and reproducible,
reaching at 10 WM the same value as the inhibition
produced by 5 Wg/ml of the anti-CD11a mAb. This
result suggested that the inhibition of cell adhesion
mediated by the integrin LFA-1 played a part in the
e¡ect of CPHS. Comparative experiments with sev-
eral steroids (not shown in Table 1) revealed that this
e¡ect was a distinctive property of CPHS. Cholester-
ol and cholesteryl acetate bearing a small head group
in the 3L-position were inactive provided transferrin
was added [17]. When the phosphoserine group was
replaced by phosphocholine (cholesteryl-3L-phospho-
choline), the cytotoxicity for the T cells increased,
indicating that hydrophilicity and group size were
critical. Among other steroids, progesterone that
mimics the inhibitory action of CPHS on cholesterol
transport to the intracellular sites of esteri¢cation
[10], was likewise inactive.
3.2. Homotypic T cell adhesion
To further investigate the CPHS e¡ect on the in-
tegrin function we examined the homotypic T cell
Table 1
Inhibitory e¡ect of CPHS on lymphocyte proliferation
Addition [3H]TdR incorporation (cpm/cultureU1033) Inhibition (%)
1. None (12) 2.9 þ 0.5
Immobilized anti-CD3, TPA (12) 78.2 þ 10.4
10 WM CPHS (12) 52.5 þ 6.7* 31.6 þ 4.3
5 Wg/ml anti-CD11a (3) 83.4 þ 2.5
2. None (6) 2.8 þ 0.2
Soluble anti-CD28, TPA (6) 77.4 þ 6.2
10 WM CPHS (5) 50.6 þ 9.2* 37.8 þ 10.6
5 Wg/ml anti-CD11a (3) 94.9 þ 3.7
3. None (12) 3.4 þ 0.5
Irradiated allogeneic cells (12) 20.4 þ 2.7
10 WM CPHS (10) 9.7 þ 1.7** 50.6 þ 6.7
5 Wg/ml anti-CD11a (5) 10.3 þ 1.4** 54.6 þ 6.3
0.8 WM cyclosporin A (4) 3.3 þ 0.6** 86.5 þ 1.5
Puri¢ed human T cell (105 cells in 0.2 ml of RPMI containing 1 mg/ml of BSA, 50 Wg/ml of transferrin and antibiotics) were incu-
bated for 10 min at 37‡C in the presence of CPHS and the indicated additions (0.1 Wg of immobilized anti-CD3; 0.2 Wg of soluble
anti-CD28; 105 irradiated allogeneic mononuclear cells ; 10 nM of TPA). 5% (v/v) fetal calf serum was then added, and the incubation
followed for 72 h (Expts. 1 and 2) or 6 days (Expt. 3). 1 WCi of [3H]TdR was added in the last 18 h of culture. Means þ S.E.M. of
the experiments indicated in parentheses, each performed in triplicate cultures. *P6 0.05; **P6 0.01.
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adhesion which re£ects the interaction of the integrin
LFA-1 with the intercellular adhesion molecules
(ICAMs) in contiguous cells [19]. Puri¢ed human T
cells incubated in the presence of fetal calf serum,
Mg2, Ca2 and TPA self-aggregated, gradually
forming large clusters (Fig. 2A). This homotypic
cell aggregation was prevented by the addition of
5 Wg/ml of anti-CD11a mAb, indicating the involve-
ment of the integrin LFA-1 and its interaction with
ICAMs (data not shown). CPHS, like the anti-
CD11a antibody, prevented the homotypic T cell
adhesion (Fig. 2B). The same result was obtained
with SKW-3 cells, a T cell line known [18] to express
LFA-1 and the three ICAMs (Fig. 2C,D). To quan-
tify the e¡ect of CPHS, the area of the T cell aggre-
gates was measured by a computerized video imaging
system coupled to an inverted microscope (see Sec-
tion 2). The results showed that the action of CPHS
was dose-dependent with an IC50 of 8 WM (Fig. 2E).
The inhibition of T cell aggregation was still present
after 72 h of incubation. To study the CPHS in£u-
ence on the integrin expression, we tested by £ow
cytometry the binding of anti CD11a mAb to
SKW-3 cells which constitutively express a high level
of LFA-1. In our conditions 79.8 þ 1.2% of the
SKW-3 cells bound the anti-CD11a mAb giving a
mean £uorescence intensity of 361.5 þ 4.6 (n = 3).
Pretreatment of the cells with 10 WM CPHS for 3 h
either in the presence or absence of 50 nM TPA did
not change these values.
3.3. T cell adhesion to ¢bronectin and rVCAM-1
To see whether CPHS was inhibitory to other in-
tegrin-mediated adhesions, we used the T cell line
Jurkat, known to express the integrins of the L1 fam-
ily involved in the adhesion of these cells to ¢bronec-
tin and to the counter-receptor vascular cell adhesion
molecule (VCAM-1). Since CPHS incorporated rap-
idly into these cells [10], its e¡ect was examined on
Fig. 2. E¡ect of CPHS on the homotypic T cell adhesion. Cells (2U105) in 0.2 ml of TBS containing 2.5% (v/v) fetal calf serum were
incubated for 20 h at 37‡C in the presence of 50 nM of TPA and, where indicated, 10 WM of CPHS. (A,B) Human T cells in the ab-
sence or in the presence of CPHS. (C,D) SKW-3 cells in the absence or in the presence of CPHS. In E the e¡ect of increasing CPHS
concentrations on the area of T cell aggregates was measured as described in Section 2. The data are expressed in pixels and represent
the mean value of the number of pixels per ¢eld times 0.001, þ S.E.M. The asterisk denotes P6 0.05. One of ¢ve experiments.
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cells shortly preincubated with the steroid (see Sec-
tion 2). As shown in Fig. 3, CPHS inhibited the
adhesion of Jurkat cells to ¢bronectin either with
or without the TPA-induced enhancement of adher-
ence [12]. In ten experiments the mean value of
CPHS IC50 was 5.3 þ 2.9 WM. Although with lower
potency, the inhibition by CPHS was also manifest in
the adhesion of Jurkat cells to rVCAM. In this case,
the CPHS IC50 was 8^10 WM in two experiments
performed in the presence of TPA. Con¢rming pre-
vious data [12], we found that the cell adhesion to
¢bronectin is a rapid process. The maximal level of
adherence by cells treated with TPA was reached in
20 min, and remained stable for at least 4 h. The
inhibition by CPHS was fully manifest in the ¢rst
2 h, slowly declining thereafter, likely due to washout
of the incorporated CPHS. Other steroids including
cholesterol, cholesteryl acetate and progesterone
were inactive (data not shown). Con¢rming the par-
ticipation of L1 integrins in the adherence to ¢bro-
nectin and rVCAM-1, a mAb (BV7) directed against
the integrin L1 subunit inhibited the adhesion of
Jurkat cells by 70^90%. A combination of antibodies
directed against the K subunit of the integrins K4L1
and K5L1 inhibited by 60% the adhesion to ¢bronec-
tin (data not shown). The BV7 mAb was selected to
test by £ow cytometry the in£uence of CPHS on L1
integrin expression. We found that 97.3 þ 0.6% of the
cells bound the antibody with a mean £uorescence
intensity of 440 þ 27 (n = 3). These values were not
changed by a cell pretreatment with 10 WM CPHS,
with or without the addition of 20 nM TPA.
3.4. Adhesion of U-937 cells to ¢bronectin
To see whether CPHS in£uenced the integrin func-
tion in other cells, we tested the monoblastic-mono-
cytic cell line U-937, known to adhere on ¢bronectin
through the integrin K5L1 [13]. In agreement, we
found that an antibody directed against the K sub-
unit of the integrin K5L1 inhibited the adhesion of
these cells to ¢bronectin by 90%, whereas an anti-
K4L1 mAb was without e¡ect (data not shown). Un-
expectedly, CPHS failed to prevent the adhesion of
U-937 cells to ¢bronectin, actually inducing stimula-
tion (Fig. 3). To exclude that the CPHS ine¡ective-
ness was due to insu⁄cient steroid incorporation into
the U-937 cells, a comparative analysis of CPHS in-
corporation was performed in Jurkat and U-937 cells
[10]. In four experiments, the addition of 20 nmol of
CPHS/106 cells caused the incorporation of 3.1 þ 2.2
nmol/106 Jurkat cells, a value close to that found in
the previous experiments [10]. In the U-937 cells the
incorporation was 4.8 þ 2.4 nmol/106 cells, corre-
sponding to 24% of the added steroid. This observa-
tion indicated that the lack of CPHS-induced inhibi-
tion in U-937 cells cannot be ascribed to insu⁄cient
steroid incorporation. Since a substrain of U-937
cells has been reported to be de¢cient in cholesterol
synthesis [20^22], we also tested the cholesterol con-
tent of our cells. Con¢rming the data on undepleted
cells [20,22], we found that the total cholesterol con-
tent of our U-937 cells was 6.7 þ 0.6 nmol/106 cells
and the total phospholipid content 25.2 þ 4.2 nmol/
106 cells (n = 4). These values were the same after the
Fig. 3. E¡ect of CPHS on cell adhesion to immobilized ¢bro-
nectin or rVCAM-1. Jurkat or U-937 cells were incubated for
30 min at 37‡C with CPHS and, when indicated, 20 nM of
TPA. After centrifugation and washing, 2U105 cells were added
to wells coated with 2 Wg of ¢bronectin or 0.2 Wg of rVCAM-1
in 0.2 ml of RPMI supplemented with BSA as described in Sec-
tion 2. Cell adherence was measured after 1 h at 37‡C. Adhe-
sion of Jurkat cells to ¢bronectin in the absence (b) or in the
presence of TPA (a). Adhesion of Jurkat cells to rVCAM-1 in
the absence (R) or in the presence of TPA (O). Adhesion of
U-937 cells to ¢bronectin in the absence (8) or in the presence
of TPA (7). Data (means þ S.E.M.) are from ten experiments
performed in triplicate (Jurkat, ¢bronectin), two experiments in
duplicate (Jurkat, rVCAM-1) or four experiments in triplicate
(U-937).
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short cell incubation in the absence of fetal calf se-
rum needed to test the adhesion to ¢bronectin. In
addition, we found that the value of total cholesterol
content was the same in cells treated or not with
CPHS, con¢rming [10] that this steroid was not hy-
drolyzed by the cholesterol esterases contained in the
cells or in the kit used for the assay.
3.5. Organization of the actin cytoskeleton
As shown by the phorbol ester- and TCR-CD3-
induced enhancement of cell adhesion without
changes in the integrin expression or a⁄nity [23^
25], a main site of integrin regulation is located at
post-receptor occupancy events. The activated signal
sequence causes the reorganization of the actin cy-
toskeleton with cell spreading on the substrate and
pseudopodal emission (reviewed in [26]). To see
whether CPHS a¡ected these processes, T cells ad-
hering on ¢bronectin were ¢xed and examined by
phase contrast microscopy or scanning electron mi-
croscopy. As shown in Fig. 4, the T cell lines, Jurkat
Fig. 4. E¡ect of CPHS on cell spreading. Control cells (2.5U104) or cells pretreated with 10 WM of CPHS were added to a ¢lm of im-
mobilized ¢bronectin and incubated for 60 min at 37‡C. Phase contrast images of adhering Jurkat cells without (a) and with (b) a
pretreatment with CPHS. Scanning electron micrographs of adhering SKW-3 cells without (c) and with (d) a pretreatment with
CPHS. Calibration bars, 50 Wm (a,b), 20 Wm (c,d).
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and SKW-3 adhering on ¢bronectin after CPHS
treatment did not show a spread morphology and
were less active in pseudopodal emission. This
CPHS e¡ect was still manifest examining the spread
morphology after 2 h of adherence to ¢bronectin.
To see whether these CPHS e¡ects were also man-
ifest when the morphological changes did not origi-
nate from the integrin occupancy but occurred in
response to intracellular events, we examined the ad-
hesion of Jurkat cells to a ¢lm of immobilized anti-
Fig. 5. Inhibition of actin polymerization in Jurkat cells adhering to anti-CD3 mAb. Cells were added to coverslips coated with 1 Wg
of anti-CD3 mAb and allowed to adhere for 10 min at 37‡C. Cells were then washed, ¢xed with 2% paraformaldehyde, permeabilized
with 0.1% Triton X-100 and stained with 1 Wg/ml of phalloidin-FITC. (a) Actin polymerization without a CPHS treatment. (b^d)
Cells pretreated with 5, 10 and 20 WM of CPHS. Calibration bar, 20 Wm. A representative of four similar experiments.
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CD3. To this end adherent cells were stained with
phalloidin-FITC. Con¢rming previous observations
[14], we found that Jurkat cells in the ¢rst 10 min
of their adhesion to immobilized anti-CD3 mAb as-
sembled a ring of polymerized actin close to the inner
edge of the plasma membrane. At the same time the
cells showed the spread morphology and irregular
contours indicative of pseudopodal emission (Fig.
5a). The ring of polymerized actin was transient
and not longer visible after 15 min [14]. After pre-
treatment with 5 WM of CPHS most of the cells
retained the round morphology and failed to pro-
duce the ring of subcortical actin (Fig. 5b). Actin
polymerization was further reduced at 10 WM of
CPHS and almost abolished at 20 WM (Fig. 5c,d).
To exclude that CPHS a¡ected the cell binding to
anti-CD3 we incubated Jurkat and puri¢ed T cells
in microtiter plates coated with the immobilized anti-
body in a time interval between 10 min and 5 h. The
pretreatment with CPHS did not inhibit the binding,
although partial cell detachment on repeated washes
(30%) indicated a weak adhesion.
3.6. Protein kinase C activity
One possible explanation of the CPHS e¡ect on
adhesion and actin polymerization was the inhibition
of PKC activity. CPHS might interact with the PKC
isoforms through its phosphoserine group. To study
this possibility, CPHS-treated Jurkat cells were
shortly incubated with TPA to induce PKC trans-
location. The PKC enzymes were then extracted
and partially puri¢ed on DEAE-cellulose. In the ab-
sence of TPA addition, the PKC activity of the cells
yielded 60 pmol of 33P incorporated into the histone
III-S/106 cells in 10 min of incubation. 93 þ 8% of
this activity was distributed in the cytosol fraction
(n = 5). After the addition of TPA, the membrane
bound activity rose to 78%. Total activity and en-
zyme translocation were not changed by a 30 min
pretreatment of the cells with 10 and 20 WM of
CPHS.
4. Discussion
Extending previous observations [8] we have
shown that the synthetic steroid CPHS negatively
a¡ects the proliferation of puri¢ed human T cells.
To de¢ne the cellular mechanism of this e¡ect, in
this study we have employed two di¡erent stimulat-
ing conditions, namely T cell triggering by antibodies
to CD3 and CD28 in the presence of a phorbol ester
and the interaction with allogeneic cells (mixed lym-
phocyte reaction). The ¢rst model has been designed
to test the e¡ect of the steroid on the signaling path-
ways activated by two major mitogenic receptors
under conditions excluding the integrin-mediated
cell-to-cell contact. In addition, the stimulation
through TCR-CD3 or CD28 in the presence of a
phorbol ester provides a means to evaluate the role
of intracellular Ca2 in the e¡ect of CPHS. Unlike
the Ca2-sensitive T cell signaling pathway activated
by TCR-CD3, the Ca2-independent pathway eli-
cited by CD28 in the presence of a phorbol ester is
not inhibited by cyclosporin A and tacrolimus [27].
The second model allowed to study the action of
CPHS when the immune response requires the integ-
rin-mediated T cell adhesion and spreading on a for-
eign cell. The data show that in the ¢rst model the
inhibitory e¡ect of CPHS, although signi¢cant, is
modest. The similar e¡ect after TCR-CD3 or CD28
stimulation indicates that the calcium sensitivity of
the pathway is not in£uent. In contrast, the e¡ect of
CPHS becomes more manifest and reproducible in
the mixed lymphocyte reaction. Since optimal T cell
proliferation requires the provision of LDL choles-
terol [28], we have ¢rst considered the possibility that
the action of CPHS is the consequence of the steroid-
induced inhibition of cholesterol transport shown be-
fore [10]. However, our comparative tests with pro-
gesterone, which mimics the action of CPHS on cho-
lesterol transport but is ine¡ective on T cell
proliferation, do not support this possibility. Consid-
ering the high steroid incorporation by the T cells
[10], we therefore propose that CPHS acts by a per-
turbation of the plasma membrane biophysical prop-
erties resulting from the insertion of a steroid ring
known to increase the rigidity of the lipid bilayer. In
addition, the incorporated CPHS has been shown
[10] to interact with the glycosphingolipid-cholester-
ol-rich membrane domains which are sites for the
accumulation of many signaling molecules and for
the initiation of actin polymerization [29,30]. These
membrane changes may explain the reduced e⁄-
ciency of signaling mechanisms, and are compatible
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with the greater sensitivity to CPHS of the mixed
lymphocyte reaction that involves the adhesive inter-
action between contiguous cells with the associated
cell shape change and cytoskeletal reorganization
[18,19,26]. In agreement, we ¢nd that a main
CPHS-induced e¡ect is the inhibition of the L1 and
L2 integrin function. Considering the role of integrins
in T cell interaction with the antigen presenting cells
and in the lymphocyte extravasation [31], this CPHS
e¡ect may be relevant to the immunosuppressive ac-
tivity shown in vivo by the steroid.
The evaluation of other steroids con¢rms that the
plasma membrane may be the main target of CPHS
e¡ect. Progesterone, cholesterol and cholesteryl ace-
tate, bearing an uncharged and small head group in
the 3-position, may be rapidly internalized and trans-
ported to the intracellular sites of their metabolism.
In accord, they are ine¡ective on T cell proliferation
and adhesive properties. In contrast, CPHS, due to
the presence of a hydrophilic head group, is not rap-
idly internalized [10], and may produce long-lasting
e¡ect in plasma membrane, as shown in this study.
The role of a polar head has been further investi-
gated by the comparison between CPHS and choles-
teryl-3L-phosphocholine. This steroid has been se-
lected because, like CPHS, it bears the head group
of a membrane phospholipid (phosphatidylcholine).
This allows the orientation of the steroid ring within
the lipid bilayer, suited to reproduce the ordering
e¡ect of cholesterol [32]. The data show that the
phosphoserine structure is preferable as a polar
group since phosphocholine enhances the surfactant
property of the amphiphile, causing cytotoxicity. Dif-
ference in size and hydrophilicity as well as the pos-
sibility of phosphoserine charge neutralization by ex-
tracellular cations may account for the distinct
properties of two polar groups [33].
To investigate whether CPHS inhibits the integrin
function by in£uencing the ligand binding site, we
tested in Jurkat and SKW-3 cells the integrin expres-
sion using inhibitory antibodies. Antibodies abrogat-
ing the integrin function have been reported to pre-
vent the binding of soluble ICAM-1 to LFA-1 [24]
and of ¢bronectin to L1 integrins [25]. The data show
that CPHS does not in£uence the binding of anti-
bodies, suggesting that the integrin ligand binding
site is not a¡ected. This conclusion has been con-
¢rmed using the monocytic cell line U-937 where,
at a comparable steroid incorporation, CPHS does
not inhibit the integrin-mediated adhesion to ¢bro-
nectin, actually causing a stimulation. We made de-
terminations of cholesterol content in these cells to
see whether the stimulating e¡ect of CPHS results
from a restoration of a cholesterol de¢ciency. U-
937 cells are known to be sensitive to their cholester-
ol content. Membrane-linked functions, including en-
docytosis [20], the appearance of the adhesive pheno-
type after the phorbol ester-induced di¡erentiation
[21] and the PAF-stimulated Ca2 mobilization [22]
are severely reduced in a cholesterol auxotroph strain
of these cells incubated for 24^48 h in the absence of
serum lipoproteins. These functions are restored by a
supply of exogenous cholesterol. At variance, our
data show that the U-937 cells used in this study
had a normal cholesterol content, not decreased by
the short incubation in a lipoprotein-free medium
needed to test the adhesion to ¢bronectin.
Two observations help to de¢ne the site of CPHS
in£uence in T cell adhesion. First, CPHS inhibits cell
spreading and pseudopodal projections which are
events following the integrin occupancy. Second,
the CPHS-induced inhibition of cell spreading and
pseudopodal organization is also manifest when
these processes are not initiated by the integrin occu-
pancy, but originate from the inside-out signals trig-
gered by the engagement of TCR-CD3. In this con-
dition we ¢nd that CPHS inhibits the assembly of
polymerized actin underlying cell spreading and
pseudopodal emission. These results suggest that
the site of CPHS inhibition is distal to the adhesion
receptors, and can be located in the metabolic se-
quence in which signals from the growth and the
adhesive receptors converge to initiate the reorgan-
ization of the actin cytoskeleton [26]. This conclusion
is consistent with the membrane changes induced by
CPHS, negatively in£uencing the connection with the
actin cytoskeleton.
A ¢nal question is whether CPHS causes its e¡ect
solely by a perturbation of the lipid organization or
whether a de¢ned signaling protein is involved. As a
¢rst attempt to address this point, we have tested the
action of the steroid on protein kinase C. The results
demonstrate that neither the activity nor the trans-
location of this signaling protein is in£uenced by
CPHS. Instead, an indication of selectivity has been
obtained in the comparison between the T cell line
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Jurkat and the monocytic cell line U-937 since in the
former CPHS inhibits the integrin-mediated adhesion
to ¢bronectin whereas in the latter it causes a slight
stimulation. This action of CPHS is reminiscent of
the e¡ect of C3-transferase from Clostridium botuli-
num, a speci¢c reagent for the small GTP-binding
Rho protein. C3-transferase prevents in T cells the
homotypic cell-to-cell adhesion [34] but in the U-937
cells it enhances the adhesion to ¢bronectin [13,35].
This di¡erence has been attributed to a distinctive
e¡ect of the Rho GTPases, Rho, Rac and Cdc42,
on the organization of the actin cytoskeleton depend-
ing on the cell type [35,36]. The di¡erent response of
T cells and U-937 cells to CPHS may be a ¢rst in-
dication that the function of the Rho GTPases is
particularly sensitive to the lipid organization im-
parted by the steroid. This possibility is now under
investigation in our laboratory.
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